- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Osteoporosis
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Abaloparatide – July 2025
Abaloparatide; Solution for injection 3 mg in 1.5 mL pre-filled pen; Eladynos®
Last updated
9 July 2025